SpaceX president Elon Musk approached the Synchron developer with an offer to invest in the company, as he was disappointed in his own startup Neuralink due to the long-term development of the brain chip. This has been reported South China Morning Post He cited four sources familiar with the situation.
According to SCMP, Musk reached out to Synchron founder and CEO Thomas Oxley to discuss a potential deal. So far, business people have not decided whether it will be just financing or a full-fledged collaboration between Synchron and Neuralink.
Synchron is based in New York. According to the sources, it is ahead of Neuralink in many developments, including the issue of conducting human trials and obtaining medical approvals for brain manipulation. If Synchron has already received such approval and has conducted its first successful human trial in the US, Neuralink plans to only begin pending human trials.
According to Neuralink’s current and four former employees, Musk has personally expressed disappointment with the slow progress of human swarf. Musk and Neuralink representatives did not respond to requests for comment, while a Synchron spokesperson declined to comment.
Earlier Musk wrote an article For the Chinese magazine China Cyberspace, he explained why people should be chipped using the development of the Neuralink initiative.
Source: Gazeta
